Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
6
×
life sciences
national blog main
boston
clinical trials
national top stories
new york blog main
san francisco blog main
startups
atlas venture
cancer
deals
dyne therapeutics
fda
gene therapy
kaleido biosciences
myotonic dystrophy type 1
rare disease drugs
san diego blog main
adeno-associated virus
allosteric
astellas pharma
atopic dermatitis
audentes therapeutics
autoimmune disorders
avidity biosciences
azacitidine
beta-thalassemia
biotech ipos
black diamond therapeutics
bladder cancer
bluebird bio
blueprint medicines
brace pharma
cancer drugs
chemotherapy
cisplatin
cleva pharma
What
medicines
6
×
therapeutics
6
×
ago
drug
ipo
new
biotech
clinic
developing
drugs
dyne
genetic
muscle
rare
research
targets
years
adding
address
adds
aiming
aims
allosteric
approach
balance
based
biotechs
black
brings
build
called
cancer
companies
company
considering
data
debuts
decibel
diamond
disease
Language
unset
6
×
Current search:
medicines
×
" boston top stories "
×
unset
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further